CVS Health Co. (NYSE:CVS) Stock Position Reduced by Montag A & Associates Inc.

Montag A & Associates Inc. lessened its position in shares of CVS Health Co. (NYSE:CVS) by 11.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 27,376 shares of the pharmacy operator’s stock after selling 3,386 shares during the period. Montag A & Associates Inc.’s holdings in CVS Health were worth $2,162,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Atticus Wealth Management LLC lifted its holdings in shares of CVS Health by 149.0% in the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 219 shares during the last quarter. Cornerstone Planning Group LLC lifted its holdings in shares of CVS Health by 111.5% in the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 243 shares during the last quarter. ZRC Wealth Management LLC raised its stake in CVS Health by 400.0% during the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after acquiring an additional 400 shares in the last quarter. Coston McIsaac & Partners raised its stake in CVS Health by 42.6% during the 4th quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator’s stock valued at $42,000 after acquiring an additional 161 shares in the last quarter. Finally, Advantage Trust Co bought a new stake in CVS Health during the 4th quarter valued at $43,000. Institutional investors own 80.66% of the company’s stock.

Insiders Place Their Bets

In related news, Director Edward J. Ludwig purchased 1,000 shares of CVS Health stock in a transaction on Thursday, May 2nd. The stock was bought at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the transaction, the director now directly owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. In other CVS Health news, Director Edward J. Ludwig acquired 1,000 shares of the company’s stock in a transaction dated Thursday, May 2nd. The shares were acquired at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the purchase, the director now owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares in the company, valued at $3,059,916.75. The disclosure for this sale can be found here. Insiders own 0.24% of the company’s stock.

CVS Health Stock Up 1.4 %

CVS traded up $0.76 during trading on Thursday, reaching $55.67. 10,298,162 shares of the stock traded hands, compared to its average volume of 11,874,933. The stock has a market cap of $69.89 billion, a price-to-earnings ratio of 9.79, a price-to-earnings-growth ratio of 0.88 and a beta of 0.56. CVS Health Co. has a fifty-two week low of $53.70 and a fifty-two week high of $83.25. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61. The stock’s 50-day simple moving average is $71.54 and its two-hundred day simple moving average is $72.96.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The firm had revenue of $88.44 billion for the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. CVS Health’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period in the previous year, the business posted $2.20 EPS. As a group, equities research analysts expect that CVS Health Co. will post 7.03 EPS for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd were given a $0.665 dividend. The ex-dividend date was Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.78%. CVS Health’s dividend payout ratio is currently 46.75%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Argus cut their target price on CVS Health from $100.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday. Mizuho lowered their price target on CVS Health from $86.00 to $72.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. Truist Financial reiterated a “buy” rating and set a $66.00 price target (down from $90.00) on shares of CVS Health in a research report on Thursday, May 2nd. Wells Fargo & Company lowered their price target on CVS Health from $76.00 to $60.00 and set an “equal weight” rating on the stock in a research report on Tuesday. Finally, UBS Group cut CVS Health from a “buy” rating to a “neutral” rating and lowered their price target for the company from $85.00 to $60.00 in a research report on Thursday, May 2nd. Nine equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $76.75.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.